MEDIAN Technologies

Median Technologies is a leading medical imaging company.

We deliver on a global scale. Our reach stretches worldwide, from the USA, the world’s largest healthcare and drug development market, across Europe, and into Asia, an increasingly important region for clinical development and healthcare markets. Our company is listed on Euronext Growth and our shareholding structure reflects our global reach, with major shareholders from China, the USA, Japan and Europe.

We, at Median, provide state of the art imaging services for oncology trials and AI medical imaging capabilities that reveal novel insights into previously unreachable knowledge. Our two proprietary platforms iSee® for imaging services in clinical trials and iBiopsy® for image-based non-invasive diagnostics, leverage the power of medical images for accelerating therapeutic innovations and improving cancer patient care.

Since our inception, we have built trusted partnerships with luminary medical centers all around the world and strategic collaborations with leading technology industries. We are a game changer and we are making a difference: our blend of science, technology, operational excellence and quality standards enables a unique approach on how medical images can unlock the power of precision medicine and lead to better outcomes for cancer and other chronic disease patients.